Pilot Study of Electronic Nicotine Delivery Systems (ENDS) Cessation Methods von Sahr, Michelle, Kelsh, Shelby, Blower, Noah, Sohn, Minji

Volltext

Viability of Virtual Skills-based Assessments Focused on Communication von VanLangen, Kali M., Sahr, Michelle J., Salvati, Lisa A., Meny, Lisa M., Bright, David R., Sohn, Minji

Volltext

Pharmacist assisted vape taper and behavioral support for cessation of electronic nicotine delivery system use von Sahr, Michelle, Kelsh, Shelby E., Blower, Noah

Volltext

Assessing the Validity and Reliability of the Pharmacist Interprofessional Competencies Tool von Salvati, Lisa A., Meny, Lisa M., de Voest, Margaret C., Bright, David R., Vavra-Janes, Kari L., Young, Mark A., Kelsh, Shelby E., Sahr, Michelle J., Wellman, Greg S.

Volltext

Patient perceptions of acute infectious disease point-of-care tests and treatment within community pharmacy settings von Sahr, Michelle, Blower, Noah, Johnston, Ryan

Volltext

Pharmacy Students’ Perceptions of Electronic Nicotine Delivery Systems as Compared to Those of Other Health Care Students von Sahr, Michelle, Kelsh, Shelby, Ottney, Anne, Young, Mark, Larson, Rodney, Sohn, Minji

Volltext

Design of a large-scale escape room for first-year pharmacy student orientation von Eric Nybo, S., Sahr, Michelle, Young, Mark, Axford, Katie, Sohn, Minji, Lyons, Margaret, Klepser, Michael

Volltext

Pharmacist assisted vape taper and behavioral support for cessation of electronic nicotine delivery system use von Sahr, Michelle, Kelsh, Shelby E, Blower, Noah

Volltext

Analysis of the androgen receptor–regulated lncRNA landscape identifies a role for ARLNC1 in prostate cancer progression von Zhang, Yajia, Pitchiaya, Sethuramasundaram, Cieślik, Marcin, Niknafs, Yashar S., Tien, Jean C.-Y., Hosono, Yasuyuki, Iyer, Matthew K., Yazdani, Sahr, Subramaniam, Shruthi, Shukla, Sudhanshu K., Jiang, Xia, Wang, Lisha, Liu, Tzu-Ying, Uhl, Michael, Gawronski, Alexander R., Qiao, Yuanyuan, Xiao, Lanbo, Dhanasekaran, Saravana M., Juckette, Kristin M., Kunju, Lakshmi P., Cao, Xuhong, Patel, Utsav, Batish, Mona, Shukla, Girish C., Paulsen, Michelle T., Ljungman, Mats, Jiang, Hui, Mehra, Rohit, Backofen, Rolf, Sahinalp, Cenk S., Freier, Susan M., Watt, Andrew T., Guo, Shuling, Wei, John T., Feng, Felix Y., Malik, Rohit, Chinnaiyan, Arul M.

Volltext

A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection von Davey, Jr, Richard T, Dodd, Lori, Proschan, Michael A, Neaton, James, Neuhaus Nordwall, Jacquie, Koopmeiners, Joseph S, Beigel, John, Tierney, John, Lane, H Clifford, Fauci, Anthony S, Massaquoi, Moses B F, Sahr, Foday, Malvy, Denis

Volltext

Phase 2 Placebo-Controlled Trial of Two Vaccines to Prevent Ebola in Liberia von Kennedy, Stephen B, Bolay, Fatorma, Kieh, Mark, Grandits, Greg, Badio, Moses, Ballou, Ripley, Eckes, Risa, Feinberg, Mark, Follmann, Dean, Grund, Birgit, Gupta, Swati, Hensley, Lisa, Higgs, Elizabeth, Janosko, Krisztina, Johnson, Melvin, Kateh, Francis, Logue, James, Marchand, Jonathan, Monath, Thomas, Nason, Martha, Nyenswah, Tolbert, Roman, François, Stavale, Eric, Wolfson, Julian, Neaton, James D, Lane, H. Clifford

Volltext

Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits von Robinson, James E., Hastie, Kathryn M., Cross, Robert W., Yenni, Rachael E., Elliott, Deborah H., Rouelle, Julie A., Kannadka, Chandrika B., Smira, Ashley A., Garry, Courtney E., Bradley, Benjamin T., Yu, Haini, Shaffer, Jeffrey G., Boisen, Matt L., Hartnett, Jessica N., Zandonatti, Michelle A., Rowland, Megan M., Heinrich, Megan L., Martínez-Sobrido, Luis, Cheng, Benson, de la Torre, Juan C., Andersen, Kristian G., Goba, Augustine, Momoh, Mambu, Fullah, Mohamed, Gbakie, Michael, Kanneh, Lansana, Koroma, Veronica J., Fonnie, Richard, Jalloh, Simbirie C., Kargbo, Brima, Vandi, Mohamed A., Gbetuwa, Momoh, Ikponmwosa, Odia, Asogun, Danny A., Okokhere, Peter O., Follarin, Onikepe A., Schieffelin, John S., Pitts, Kelly R., Geisbert, Joan B., Kulakoski, Peter C., Wilson, Russell B., Happi, Christian T., Sabeti, Pardis C., Gevao, Sahr M., Khan, S. Humarr, Grant, Donald S., Geisbert, Thomas W., Saphire, Erica Ollmann, Branco, Luis M., Garry, Robert F.

Volltext

Progression-Free Survival and Patterns of Response in Patients With Relapsed High-Risk Neuroblastoma Treated With Irinotecan/Temozolomide/Dinutuximab/Granulocyte-Macrophage Colony-... von Lerman, Benjamin J, Li, Yimei, Carlowicz, Cecilia, Granger, Meaghan, Cash, Thomas, Sadanand, Arhanti, Somers, Katherine, Ranavaya, Aeesha, Weiss, Brian D, Choe, Michelle, Foster, Jennifer H, Pinto, Navin, Morgenstern, Daniel A, Rafael, Margarida Simão, Streby, Keri A, Zeno, Rachel N, Mody, Rajen, Yazdani, Sahr, Desai, Ami V, Macy, Margaret E, Shusterman, Suzanne, Federico, Sara M, Bagatell, Rochelle

Volltext

Progression-free survival and patterns of response in patients with high-risk neuroblastoma (HR-NB) treated with irinotecan/temozolomide/dinutuximab/granulocyte-macrophage colony-s... von Lerman, Benjamin, Li, Yimei, Granger, Meaghan, Cash, Thomas, Sadanand, Arhanti, Somers, Katherine, Ranavaya, Aeesha, Choe, Michelle, Foster, Jennifer, Morgenstern, Daniel A., Rafael, Margarida Simao, Streby, Keri A., Zeno, Rachel, Mody, Rajen, Yazdani, Sahr, Desai, Ami Vijay, Macy, Margaret E, Shusterman, Suzanne, Federico, Sara Michele, Bagatell, Rochelle

Volltext

Safety, Tolerability, and Efficacy of a 7-Day Cleanse Program: A Pilot Study von Lau, Francis C, Sahr, Nedra, Carrillo-Massa, Michelle, Fyrberg, Chelsea, Daggy, Bruce, McManus, Jamie

Volltext

Parainfluenza Virus Infection Among Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Children and Adults Hospitalized for Severe Acute Respiratory Illness in South Af... von Cohen, Adam L., Sahr, Philip K., Treurnicht, Florette, Walaza, Sibongile, Groome, Michelle J., Kahn, Kathleen, Dawood, Halima, Variava, Ebrahim, Tempia, Stefano, Pretorius, Marthi, Moyes, Jocelyn, Olorunju, Steven A. S., Malope-Kgokong, Babatyi, Kuonza, Lazarus, Wolter, Nicole, von Gottberg, Anne, Madhi, Shabir A., Venter, Marietjie, Cohen, Cheryl

Volltext

Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits von Robinson, James E, Hastie, Kathryn M, Cross, Robert W, Yenni, Rachael E, Elliott, Deborah H, Rouelle, Julie A, Kannadka, Chandrika B, Smira, Ashley A, Garry, Courtney E, Bradley, Benjamin T, Yu, Haini, Shaffer, Jeffrey G, Boisen, Matt L, Hartnett, Jessica N, Zandonatti, Michelle A, Rowland, Megan M, Heinrich, Megan L, Martínez-Sobrido, Luis, Cheng, Benson, de la Torre, Juan C, Andersen, Kristian G, Goba, Augustine, Momoh, Mambu, Fullah, Mohamed, Gbakie, Michael, Kanneh, Lansana, Koroma, Veronica J, Fonnie, Richard, Jalloh, Simbirie C, Kargbo, Brima, Vandi, Mohamed A, Gbetuwa, Momoh, Ikponmwosa, Odia, Asogun, Danny A, Okokhere, Peter O, Follarin, Onikepe A, Schieffelin, John S, Pitts, Kelly R, Geisbert, Joan B, Kulakoski, Peter C, Wilson, Russell B, Happi, Christian T, Sabeti, Pardis C, Gevao, Sahr M, Khan, S. Humarr, Grant, Donald S, Geisbert, Thomas W, Saphire, Erica Ollmann, Branco, Luis M, Garry, Robert F

Volltext